ACTA1 and diabetic cardiomyopathy: Li et al. [35] illustrated that tetrahydrocurcumin treatment could alleviate diabetic cardiomyopathy by reducing the expression of α-SMA, collagen I, and collagen III, which are markers of cardiac fibrosis.